Bangkok – AstraZeneca (Thailand) Company Limited has signed a Memorandum of Understanding (MoU) with Phyathai 2 Hospital to use AI-based technology for chest X-rays in the hospital.

Phyathai 2 Hospital has moved forward with its “Centres of Excellence” policy, investing more than Bt100 million into its Heart Centre in an effort to optimise the quality of care and outfit the hospital with the most cutting-edge medical technology in a bid to make it the foremost cardiac treatment centre in Asia.